| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1041369262 |
| P356 | DOI | 10.1385/IR:34:3:193 |
| P698 | PubMed publication ID | 16891671 |
| P50 | author | Adam E Mullick | Q46902381 |
| P2093 | author name string | Peter S Tobias | |
| Linda K Curtiss | |||
| P2860 | cites work | TLR4 mutations are associated with endotoxin hyporesponsiveness in humans | Q22254186 |
| Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime | Q28212769 | ||
| Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease | Q28239710 | ||
| The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults | Q28289939 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice | Q28505210 | ||
| Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice | Q28591350 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function | Q29617462 | ||
| T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses | Q33819043 | ||
| The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
| The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages | Q33895703 | ||
| Background and current knowledge of Chlamydia pneumoniae and atherosclerosis | Q33935003 | ||
| Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging | Q33946993 | ||
| Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney | Q33948196 | ||
| Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product | Q47072878 | ||
| Genetic Control of Leucocyte Responses to Endotoxin | Q50245835 | ||
| A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. | Q52938770 | ||
| Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. | Q54730930 | ||
| Evolutionary theories of aging and longevity. | Q55423549 | ||
| TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis | Q57416741 | ||
| Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction*1 | Q57607713 | ||
| Infection, Inflammation, and Atherosclerosis | Q58771301 | ||
| Toll-like Receptor 4 Polymorphisms and Atherogenesis | Q59273869 | ||
| Effect of repeated endotoxin treatment and hypercholesterolemia on preatherosclerotic lesions in weaned pigs Part 1. Scanning and transmission electron microscopic study | Q59704437 | ||
| In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions | Q59981316 | ||
| Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice | Q62735862 | ||
| Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling | Q63915511 | ||
| Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls | Q71618243 | ||
| Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation | Q74144043 | ||
| Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation | Q77753940 | ||
| Inflammation and atherosclerosis | Q80015206 | ||
| A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection | Q34005032 | ||
| Modulation of atherosclerosis in mice by Toll-like receptor 2 | Q34063165 | ||
| Regulation of lung injury and repair by Toll-like receptors and hyaluronan | Q34462186 | ||
| Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs | Q34890336 | ||
| Anti-inflammatory lipid mediators and insights into the resolution of inflammation | Q34931955 | ||
| Imaging of atherosclerosis. Remodelling of coronary arteries. | Q34977664 | ||
| Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators | Q35578683 | ||
| Inferences, questions and possibilities in Toll-like receptor signalling | Q35829752 | ||
| Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries | Q35833909 | ||
| Toll-like receptors in the pathogenesis of human disease | Q35904386 | ||
| Genetics of atherosclerosis | Q35918548 | ||
| Nuclear factor kappaB signaling in atherogenesis. | Q36054434 | ||
| The role of natural antibodies in atherogenesis | Q36129564 | ||
| Infectious agents are not necessary for murine atherogenesis | Q36368432 | ||
| IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis | Q36849075 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligand | Q37608463 | ||
| Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial | Q37868604 | ||
| Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial | Q37869839 | ||
| Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice | Q37874064 | ||
| Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice | Q37874405 | ||
| Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice | Q39802780 | ||
| Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. | Q40514826 | ||
| Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet | Q40597623 | ||
| Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 | ||
| The response of recombinant inbred strains of mice to bacterial lipopolysaccharides | Q40773915 | ||
| The extra domain A of fibronectin activates Toll-like receptor 4. | Q40832345 | ||
| Effect of bacterial lipopolysaccharide on serum lipids and on the development of aortic atherosclerosis in rabbits | Q41494190 | ||
| Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent | Q41572162 | ||
| Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism | Q41737918 | ||
| Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. | Q42514406 | ||
| A role for oxidized phospholipids in atherosclerosis | Q43686230 | ||
| Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. | Q43748246 | ||
| The role of immune activation in endotoxin-induced atherogenesis | Q43805487 | ||
| Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events | Q44438477 | ||
| Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. | Q44620786 | ||
| Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis | Q44771606 | ||
| Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma | Q44772766 | ||
| Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways | Q44807760 | ||
| Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity | Q45042580 | ||
| Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis | Q45261400 | ||
| Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development | Q46380675 | ||
| Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility | Q46593667 | ||
| P433 | issue | 3 | |
| P921 | main subject | toll-like receptor | Q408004 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 193-209 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | Toll-like receptors and atherosclerosis: key contributors in disease and health? | |
| P478 | volume | 34 |
| Q39426447 | Atorvastatin inhibits functional expression of proatherogenic TLR2 in arterial endothelial cells. |
| Q41969861 | Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo |
| Q33789216 | Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury |
| Q36897400 | Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions |
| Q33937994 | Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications |
| Q33693974 | Diabetes is a proinflammatory state: a translational perspective |
| Q93832772 | Does angiotensin-II link arteries and monocytes? |
| Q37326042 | Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice |
| Q37388603 | Expression of toll-like receptor 4 in maternal monocytes of patients with gestational diabetes mellitus |
| Q33919459 | Glutathione peroxidase-1 modulates lipopolysaccharide-induced adhesion molecule expression in endothelial cells by altering CD14 expression |
| Q37593102 | Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development |
| Q36312635 | Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy |
| Q28474725 | Identification of potential pathway mediation targets in Toll-like receptor signaling |
| Q92876531 | Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques |
| Q38734509 | Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus |
| Q33318184 | Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events |
| Q37259921 | Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes |
| Q37408117 | Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway |
| Q36459935 | Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state |
| Q35841261 | Increased toll-like receptor activity in patients with metabolic syndrome |
| Q36929586 | Innate immunity and aging |
| Q39418237 | Mechanisms of erosion of atherosclerotic plaques. |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q37281187 | Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice |
| Q41894655 | Role of MyD88-dependent and MyD88-independent signaling in Porphyromonas gingivalis-elicited macrophage foam cell formation. |
| Q36825685 | Short-term exercise training improves insulin sensitivity but does not inhibit inflammatory pathways in immune cells from insulin-resistant subjects |
| Q37023850 | TLR2 in murine atherosclerosis |
| Q37490923 | TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases |
| Q83401137 | The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications |
| Q40198481 | The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells |
| Q35564034 | The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity |
| Q45323315 | Toll-like receptor activity in patients with obstructive sleep apnea |
| Q35581147 | Toll-like receptors (TLRs) in transplantation |
| Q36944764 | Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache. |
| Q40402994 | miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages |
Search more.